

Cover Story
FreeObituary
John Mark Cleland died peacefully on Feb. 7, 2022, in Indianapolis. Some people reading this headline will have little or no idea who John Cleland was. However, if you are a medical or urological oncologist, you should. John Cleland was the first man whose metastatic testicular cancer was cured with combination chemotherapy containing cisplatin.
Black History MonthCancer History ProjectFree
By Alexandria Carolan and Alice Tracey
In Brief


Clinical Roundup


Trending Stories
- NIH Director Jay Bhattacharya launches a podcast
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
- “Forward funding” NIH budget plan would make competing for grants much harder
- In the Headlines: What if curing diseases was treated like a business?